Immix Biopharma, Inc. (NASDAQ:IMMX) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Announced: US$125M · US$11 a share · J.P. Morgan Dealers: J.P. Morgan (lead) Buyers: Eventide Asset Management; Janus Henderson Investors; Ridgeback Capital Investments L.P.; Wellington Management Use of proceeds: Fund NXC-201 development, working capital and general corporate purposes | Sep 29, 2026 |
| Public offering of common stock and pre-funded warrants Announced: US$100M · US$5.1 a share · Morgan Stanley +2 Dealers: Morgan Stanley (lead), Citizens Capital Markets, Mizuho Use of proceeds: Fund NXC-201 development, working capital and general corporate purposes | Dec 7, 2025 |
| Strategic investment of strategic investment Closed: strategic investment Buyers: Goose Capital; Dr. Nancy T. Chang | Sep 8, 2025 |